<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03792191</url>
  </required_header>
  <id_info>
    <org_study_id>MD.18.02.29</org_study_id>
    <nct_id>NCT03792191</nct_id>
  </id_info>
  <brief_title>Ultrasonography Versus Palpation for Spinal Anesthesia in Obese Parturients Undergoing Cesarean Delivery</brief_title>
  <official_title>Ultrasonography Versus Palpation for Spinal Anesthesia in Obese Parturients Undergoing Cesarean Delivery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will compare between preprocedural ultrasonography and the conventional palpation
      technique for spinal anesthesia in obese parturients undergoing elective cesarean delivery
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This randomized, controlled, double-blind study will be conducted on ASA physical status
      II-III obese parturients with full-term singleton pregnancy undergoing elective cesarean
      delivery under spinal anesthesia. The study subjects will be assigned to 2 equal groups. In
      the ultrasonography group, lumbar spinal ultrasonography will be performed before
      administration of spinal anesthesia. In the palpation group, conventional palpation of the
      anatomical landmarks will be performed.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 16, 2019</start_date>
  <completion_date type="Anticipated">June 2020</completion_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of needle passes required to obtain free cerebrospinal fluid flow</measure>
    <time_frame>Assessed from enrollment in the study up to completion of cesarean delivery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of skin punctures required to obtain free cerebrospinal fluid flow</measure>
    <time_frame>Assessed from enrollment in the study up to completion of cesarean delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of successful obtaining of free cerebrospinal fluid flow at the first needle pass</measure>
    <time_frame>Assessed from enrollment in the study up to completion of cesarean delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of successful obtaining of free cerebrospinal fluid flow at the first skin puncture</measure>
    <time_frame>Assessed from enrollment in the study up to completion of cesarean delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of the procedure</measure>
    <time_frame>Assessed from enrollment in the study up to completion of cesarean delivery</time_frame>
    <description>The time from the first needle pass until obtaining free cerebrospinal fluid flow</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction from the procedure</measure>
    <time_frame>Assessed at 1 minute after intrathecal injection</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of unintentional vascular puncture</measure>
    <time_frame>Assessed from enrollment in the study up to completion of cesarean delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of paresthesia</measure>
    <time_frame>Assessed from enrollment in the study up to completion of cesarean delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of failure of obtaining free cerebrospinal fluid flow</measure>
    <time_frame>Assessed from enrollment in the study up to completion of cesarean delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of failed block</measure>
    <time_frame>Assessed up to 20 minutes after intrathecal injection</time_frame>
    <description>Upper sensory level below T6</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">280</enrollment>
  <condition>Anesthesia, Spinal</condition>
  <condition>Cesarean Section</condition>
  <condition>Spinal Ultrasound</condition>
  <arm_group>
    <arm_group_label>Ultrasonography</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Preprocedural lumbar spinal ultrasonography and skin marking. Spinal anesthesia will be administered with injection of intrathecal bupivacaine and intrathecal fentanyl.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Palpation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sham ultrasound procedure. Conventional landmark palpation and skin marking.Spinal anesthesia will be administered with injection of intrathecal bupivacaine and intrathecal fentanyl.</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Lumbar Spinal Ultrasonography</intervention_name>
    <description>Ultrasonography of the lumbar spines using an 8-2 MHz curved array transducer. Identification of the intervertebral space with the best image. Marking the patient`s skin with horizontal and vertical lines over the L3-L4 and L2-L3 intervertebral spaces.</description>
    <arm_group_label>Ultrasonography</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Sham Ultrasound Procedure</intervention_name>
    <description>Moving the ultrasound probe on the patient's back with the machine in the freeze position.</description>
    <arm_group_label>Palpation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conventional Landmark Palpation</intervention_name>
    <description>Conventional palpation of the anatomical landmarks. The line crossing the iliac crests (Tuffier line) is assumed to cross the spine at L4 spinous process or L3-L4 intervertebral space. Identification of the widest intervertebral space. Marking the patient`s skin with horizontal and vertical lines over the L3-L4 and L2-L3 intervertebral spaces.</description>
    <arm_group_label>Palpation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Spinal Anesthesia</intervention_name>
    <description>Spinal anesthesia using a 25- or 22-gauge spinal needle</description>
    <arm_group_label>Palpation</arm_group_label>
    <arm_group_label>Ultrasonography</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intrathecal Bupivacaine</intervention_name>
    <description>Bupivacaine 12.5 mg (2.5 mL 0.5%) will be administered in the subarachnoid space</description>
    <arm_group_label>Palpation</arm_group_label>
    <arm_group_label>Ultrasonography</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intrathecal Fentanyl</intervention_name>
    <description>Fentanyl 15 μg will be administered in the subarachnoid space</description>
    <arm_group_label>Palpation</arm_group_label>
    <arm_group_label>Ultrasonography</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists physical status II-III parturients

          -  Full term singleton pregnancy

          -  Body mass index ≥ 35 Kg/m2

        Exclusion Criteria:

          -  Age &lt; 19 years

          -  Women presenting in labor

          -  Contraindications to neuraxial anesthesia (Coagulopathy, increased intracranial
             pressure, or local skin infection)

          -  Significant spinal deformities or previous spinal surgery

          -  Preeclampsia
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohamed M Tawfik, MD</last_name>
    <role>Study Director</role>
    <affiliation>Mansoura University Hospitals</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohamed A Tolba, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mansoura University Hospitals</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mohamed M Tawfik, MD</last_name>
    <phone>1001183400</phone>
    <phone_ext>0020</phone_ext>
    <email>m2tawfik@mans.edu.eg</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Anesthesia, Mansoura University Hospitals</name>
      <address>
        <city>Mansoura</city>
        <state>Dakahlia</state>
        <zip>35511</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohamed M Tawfik, MD</last_name>
      <phone>1001183400</phone>
      <phone_ext>0020</phone_ext>
      <email>m2tawfik@mans.edu.eg</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>January 1, 2019</study_first_submitted>
  <study_first_submitted_qc>January 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 3, 2019</study_first_posted>
  <last_update_submitted>February 20, 2020</last_update_submitted>
  <last_update_submitted_qc>February 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Mohamed Mohamed Tawfik</investigator_full_name>
    <investigator_title>Lecturer, Department of anesthesia and surgical intensive care, Primary investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

